FDA Advisory Panel Consistency Will Be Focus In Coming Years - Henney
This article was originally published in The Gray Sheet
Executive Summary
FDA can improve the training and orientation of advisory committee/panel members to ensure greater consistency in the process, former FDA Commissioner Jane Henney, MD, told the Goldman Sachs health care conference June 12 in Laguna Niguel, California.